PembrolizumabPericardial effusion and cardiac tamponade: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1938卷 / 1期

关键词：

D O I：

10.1007/s40278-023-31204-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：1063 / 1063

相关论文

共 50 条

[1] PembrolizumabPericardial effusion, cardiac tamponade and lack of efficacy: case report
[J]. Reactions Weekly, 2023, 1979 (1) : 379 - 379
[2] PembrolizumabPericardial tamponade: case report
[J]. Reactions Weekly, 2020, 1806 (1) : 225 - 225
[3] PembrolizumabPericardial tamponade: case report
[J]. Reactions Weekly, 2019, 1745 (1) : 219 - 219
[4] PembrolizumabPericardial tamponade: case report
[J]. Reactions Weekly, 2023, 1965 (1) : 401 - 401
[5] PembrolizumabPericardial effusion: case report
[J]. Reactions Weekly, 2022, 1928 (1) : 304 - 304
[6] PembrolizumabPericardial effusion: case report
[J]. Reactions Weekly, 2020, 1823 (1) : 291 - 291
[7] PembrolizumabPericardial effusion: case report
[J]. Reactions Weekly, 2020, 1814 (1) : 291 - 291
[8] InfliximabPericardial effusion and cardiac tamponade: case report
[J]. Reactions Weekly, 2019, 1760 (1) : 117 - 117
[9] IbrutinibHaemorrhagic pericardial effusion and cardiac tamponade: case report
[J]. Reactions Weekly, 2020, 1787 (1) : 269 - 269
[10] CytarabineHaemorrhagic pericardial effusion and cardiac tamponade: case report
[J]. Reactions Weekly, 2020, 1823 (1) : 137 - 137

← 1 2 3 4 5 →